Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
Elffors I, Allander E, Kanis JA et al. (1994) The variable incidence of hip fracture in southern Europe: the MEDOS study. Osteoporos Int 4:253–263
2.
Dilsen G, Aydın R, Oral A et al. (1993) Regional differences in hip fracture risk in Turkey. Bone 14:65–68
3.
Ross PD, He Y, Yates AJ et al. (1996) Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort ) Study Group. Calcif Tiss Int 59:339–343
4.
Perez Cano R, Galan F, Dilsen G (1993) Risk factors for hip fracture in Spanish and Turkish women. Bone 14 (Suppl 1):69–72
Metadata
Title
Discrepancies between hip BMD and fracture rate in Turkey: a familiar problem
Authors
Ş. Tüzün
İ. Karacan
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 3/2003
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-003-1392-5

Other articles of this Issue 3/2003

Osteoporosis International 3/2003 Go to the issue

Original Article

Tolerability and compliance with risedronate in clinical practice

Review

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review

Original Article

Total dose incurred by patients and staff from BMD measurement using a new 2D digital bone densitometer

Original Article

Risk factors for Colles' fracture in men and women: results from the European Prospective Osteoporosis Study

Original Article

Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN

Original Article

A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)